Sinovac’s COVID-19 vaccine is conditionally registered in South Africa
Sinovac’s COVID-19 vaccine is conditionally registered in South Africa

Sinovac’s COVID-19 vaccine is conditionally registered in South Africa

A vial marked “Sinovac COVID-19 Vaccine” is shown in this illustration taken January 16, 2022. REUTERS / Dado Ruvic / Illustration

Sign up now for FREE unlimited access to Reuters.com

June 25 (Reuters) – China’s Sinovac Biotech (SVA.O) said on Saturday that the South African Health Products Regulatory Authority has granted conditional registration of its coronavirus vaccine CoronaVac to persons aged 18 and over.

Sign up now for FREE unlimited access to Reuters.com

Reporting of Akanksha Khushi in Bengaluru; Editing Sam Holmes

Our standards: Thomson Reuters trust principles.

Leave a Reply

Your email address will not be published.